An evolutionary genomic approach reveals both conserved and species-specific genetic elements related to human disease in closely related Aspergillus fungi.


Journal

Genetics
ISSN: 1943-2631
Titre abrégé: Genetics
Pays: United States
ID NLM: 0374636

Informations de publication

Date de publication:
24 06 2021
Historique:
received: 11 03 2021
accepted: 20 04 2021
pubmed: 5 5 2021
medline: 22 2 2022
entrez: 4 5 2021
Statut: ppublish

Résumé

Aspergillosis is an important opportunistic human disease caused by filamentous fungi in the genus Aspergillus. Roughly 70% of infections are caused by Aspergillus fumigatus, with the rest stemming from approximately a dozen other Aspergillus species. Several of these pathogens are closely related to A. fumigatus and belong in the same taxonomic section, section Fumigati. Pathogenic species are frequently most closely related to nonpathogenic ones, suggesting Aspergillus pathogenicity evolved multiple times independently. To understand the repeated evolution of Aspergillus pathogenicity, we performed comparative genomic analyses on 18 strains from 13 species, including 8 species in section Fumigati, which aimed to identify genes, both ones previously connected to virulence as well as ones never before implicated, whose evolution differs between pathogens and nonpathogens. We found that most genes were present in all species, including approximately half of those previously connected to virulence, but a few genes were section- or species-specific. Evolutionary rate analyses identified over 1700 genes whose evolutionary rate differed between pathogens and nonpathogens and dozens of genes whose rates differed between specific pathogens and the rest of the taxa. Functional testing of deletion mutants of 17 transcription factor-encoding genes whose evolution differed between pathogens and nonpathogens identified eight genes that affect either fungal survival in a model of phagocytic killing, host survival in an animal model of fungal disease, or both. These results suggest that the evolution of pathogenicity in Aspergillus involved both conserved and species-specific genetic elements, illustrating how an evolutionary genomic approach informs the study of fungal disease.

Identifiants

pubmed: 33944921
pii: 6263860
doi: 10.1093/genetics/iyab066
pmc: PMC8225353
pii:
doi:

Substances chimiques

Fungal Proteins 0
Transcription Factors 0
Virulence Factors 0

Banques de données

figshare
['10.6084/m9.figshare.14424386']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R56 AI146096
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Microbiology (Reading). 2014 Apr;160(Pt 4):742-751
pubmed: 24464798
Nucleic Acids Res. 2013 Jan;41(Database issue):D358-65
pubmed: 23180791
mBio. 2017 Feb 21;8(1):
pubmed: 28223452
Trends Ecol Evol. 2000 Dec 1;15(12):496-503
pubmed: 11114436
mBio. 2021 Feb 16;12(1):
pubmed: 33593969
Mol Cell Proteomics. 2013 Jul;12(7):1791-805
pubmed: 23599423
Nature. 2003 Oct 23;425(6960):798-804
pubmed: 14574403
G3 (Bethesda). 2017 May 5;7(5):1475-1485
pubmed: 28292787
Antimicrob Agents Chemother. 2013 Jul;57(7):3380-7
pubmed: 23669377
mSphere. 2019 Feb 20;4(1):
pubmed: 30787113
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E753-E761
pubmed: 29317534
Microbiol Spectr. 2021 Jun 9;:e0001021
pubmed: 34106569
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17065-70
pubmed: 24082142
Virulence. 2018;9(1):1548-1561
pubmed: 30251593
PLoS Pathog. 2012;8(10):e1002936
pubmed: 23055925
Eukaryot Cell. 2013 Dec;12(12):1619-28
pubmed: 24123268
Annu Rev Genet. 2019 Dec 3;53:417-444
pubmed: 31537103
J Clin Microbiol. 2014 Oct;52(10):3707-21
pubmed: 25100816
J Fungi (Basel). 2018 Mar 20;4(1):
pubmed: 30152809
Eukaryot Cell. 2011 Jan;10(1):34-42
pubmed: 21076011
J Mol Evol. 1981;17(6):368-76
pubmed: 7288891
Curr Protoc Microbiol. 2019 Sep;54(1):e88
pubmed: 31518064
J Med Microbiol. 1996 Sep;45(3):186-91
pubmed: 8810945
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
IUBMB Life. 2020 Nov;72(11):2303-2312
pubmed: 32897638
Evolution. 2009 Jan;63(1):1-19
pubmed: 19146594
Nucleic Acids Res. 2020 Jan 8;48(D1):D613-D620
pubmed: 31733065
PLoS Biol. 2017 Nov 17;15(11):e2003583
pubmed: 29149178
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
mBio. 2020 Feb 11;11(1):
pubmed: 32047138
Chembiochem. 2007 Jul 9;8(10):1154-61
pubmed: 17525915
PLoS Pathog. 2008 Sep 12;4(9):e1000154
pubmed: 18787699
Eukaryot Cell. 2007 Dec;6(12):2169-74
pubmed: 17951515
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Mol Biol Evol. 1995 Jul;12(4):546-57
pubmed: 7659011
PLoS Genet. 2008 Apr 11;4(4):e1000046
pubmed: 18404212
Antimicrob Agents Chemother. 2004 Nov;48(11):4405-13
pubmed: 15504870
mBio. 2019 Jul 9;10(4):
pubmed: 31289177
PLoS Pathog. 2020 Feb 27;16(2):e1008315
pubmed: 32106242
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Mol Biol Evol. 2007 Aug;24(8):1586-91
pubmed: 17483113
PLoS Pathog. 2015 Apr 24;11(4):e1004834
pubmed: 25909486
Rev Iberoam Micol. 2010 Oct-Dec;27(4):155-82
pubmed: 20974273
Cold Spring Harb Perspect Med. 2014 Nov 06;5(2):a019786
pubmed: 25377144
FEMS Microbiol Lett. 2016 Feb;363(3):
pubmed: 26667219
Cold Spring Harb Perspect Med. 2014 Nov 10;5(9):
pubmed: 25384770
Bioinformatics. 2021 Feb 09;:
pubmed: 33560364
Semin Respir Crit Care Med. 2015 Oct;36(5):662-72
pubmed: 26398533
Mycopathologia. 2014 Oct;178(3-4):163-76
pubmed: 25106755
Bioinformatics. 2003 Oct;19 Suppl 2:ii215-25
pubmed: 14534192
Infect Immun. 2006 Dec;74(12):6761-8
pubmed: 17030582
Eukaryot Cell. 2007 May;6(5):868-74
pubmed: 17384199
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722890
mSphere. 2017 Feb 1;2(1):
pubmed: 28168221
Genome Res. 2009 Oct;19(10):1722-31
pubmed: 19717792
J Clin Microbiol. 2009 Oct;47(10):3138-41
pubmed: 19675215
PLoS Biol. 2019 May 21;17(5):e3000255
pubmed: 31112549
Nat Commun. 2020 Jan 22;11(1):427
pubmed: 31969561
J Mol Evol. 1994 Sep;39(3):306-14
pubmed: 7932792
Fungal Biol Biotechnol. 2019 Jul 1;6:2
pubmed: 31304040
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
mSphere. 2020 Apr 8;5(2):
pubmed: 32269156
Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709):
pubmed: 28080993
Sci Rep. 2018 Jul 18;8(1):10872
pubmed: 30022098
mBio. 2015 Jun 02;6(3):e00536
pubmed: 26037120
Eukaryot Cell. 2007 Jun;6(6):949-59
pubmed: 17449657
Genome Res. 2003 Sep;13(9):2178-89
pubmed: 12952885
Antimicrob Agents Chemother. 2003 May;47(5):1719-26
pubmed: 12709346
Mycopathologia. 2014 Dec;178(5-6):427-33
pubmed: 24972670
FEMS Yeast Res. 2016 Sep;16(6):
pubmed: 27493146
Environ Microbiol. 2019 May;21(5):1809-1820
pubmed: 30868709
PLoS One. 2013 Jun 14;8(6):e64871
pubmed: 23798996
Microbiol Resour Announc. 2018 Dec 6;7(22):
pubmed: 30533860
Virulence. 2010 Nov-Dec;1(6):475-82
pubmed: 21178491
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Nat Microbiol. 2019 Dec;4(12):2430-2441
pubmed: 31548684
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
J Microbiol. 2016 Mar;54(3):243-53
pubmed: 26920884
Nature. 2009 Jun 4;459(7247):657-62
pubmed: 19465905
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
EMBO J. 1997 Sep 1;16(17):5376-85
pubmed: 9311997
Lancet Infect Dis. 2017 Dec;17(12):e383-e392
pubmed: 28774698
Bioinformatics. 2009 Aug 1;25(15):1972-3
pubmed: 19505945
mBio. 2016 Sep 20;7(5):
pubmed: 27651366
Curr Biol. 2020 Jul 6;30(13):2495-2507.e7
pubmed: 32502407
Stud Mycol. 2020 Jun 27;95:5-169
pubmed: 32855739
Bioinformatics. 2012 Jan 1;28(1):48-55
pubmed: 22039210
Bioinformatics. 2017 Sep 15;33(18):2938-2940
pubmed: 28645171
Front Microbiol. 2019 Sep 04;10:1970
pubmed: 31551947
Genetics. 2020 Oct;216(2):481-497
pubmed: 32817009
Nat Commun. 2020 Feb 27;11(1):1106
pubmed: 32107379
Front Microbiol. 2019 Apr 24;10:854
pubmed: 31105662
G3 (Bethesda). 2016 Dec 7;6(12):4023-4033
pubmed: 27694115
mBio. 2020 May 26;11(3):
pubmed: 32457245
Appl Environ Microbiol. 2011 Jul;77(13):4700-3
pubmed: 21602378
Environ Microbiol. 2015 Aug;17(8):2858-69
pubmed: 25684622
Front Genet. 2020 May 12;11:459
pubmed: 32477406
Mol Biol Evol. 2018 Mar 1;35(3):543-548
pubmed: 29220515
Curr Opin Microbiol. 2005 Aug;8(4):385-92
pubmed: 16019255
Front Microbiol. 2016 Jan 07;6:1485
pubmed: 26779142
BMC Bioinformatics. 2018 May 8;19(Suppl 6):153
pubmed: 29745866
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Med Mycol. 2015 Nov;53(8):765-97
pubmed: 26316211
J Fungi (Basel). 2017 Oct 18;3(4):
pubmed: 29371573

Auteurs

Matthew E Mead (ME)

Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.

Jacob L Steenwyk (JL)

Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.

Lilian P Silva (LP)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.

Patrícia A de Castro (PA)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.

Nauman Saeed (N)

Junior Research Group Evolution of Microbial Interactions, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany.

Falk Hillmann (F)

Junior Research Group Evolution of Microbial Interactions, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany.

Gustavo H Goldman (GH)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.

Antonis Rokas (A)

Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH